1762
中化生
0.00 (0.00%)33.5030成交張數–本益比0.80股價淨值比0.00%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入2025805年增 -40.3%
毛利率2025-1.1%最新一期
營業利益率2025-39.7%最新一期
每股盈餘2025-4.39年增 -562.1%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | -2.5% | -12.7% | +13.5% | +33.5% | +25.3% | +9.4% | -1.5% | -35.4% | -40.3% | |
| 營業成本合計 | – | -3.0% | -12.2% | +3.0% | +24.5% | +15.0% | +17.3% | +15.0% | -28.3% | -14.6% | |
| 營業毛利（毛損） | – | -1.6% | -13.8% | +33.3% | +46.5% | +38.2% | +1.3% | -21.3% | -47.9% | -102.2% | |
| 營業毛利（毛損）淨額 | – | -1.6% | -13.8% | +33.3% | +46.5% | +38.2% | +1.3% | -21.3% | -47.9% | -102.2% | |
| 推銷費用 | – | -1.8% | -6.9% | -4.0% | +45.1% | +31.9% | +12.3% | -20.5% | -25.9% | -24.9% | |
| 管理費用 | – | +14.3% | -16.1% | -4.8% | +20.9% | +3.1% | +14.8% | -4.3% | -17.4% | -18.5% | |
| 研究發展費用 | – | +2.0% | +8.2% | +21.0% | +10.4% | +17.1% | -3.1% | -0.9% | -15.2% | -18.2% | |
| 營業費用合計 | – | +4.2% | -2.8% | +8.4% | +20.2% | +22.3% | -2.5% | -4.4% | -18.6% | -19.9% | |
| 營業利益（損失） | – | -20.4% | -60.4% | +291.0% | +122.0% | +63.1% | +5.7% | -39.4% | -97.7% | – | |
| 利息收入 | – | – | – | – | – | -57.3% | – | +61.3% | -40.0% | -13.2% | |
| 其他收入 | – | +57.0% | +7.7% | -36.4% | +17.4% | +70.8% | -49.6% | +14.7% | +32.0% | -40.2% | |
| 其他利益及損失淨額 | – | – | +677.2% | -102.1% | – | -101.9% | – | -72.7% | -50.0% | +25.9% | |
| 財務成本淨額 | – | +27.2% | +30.2% | -2.3% | -55.2% | -30.2% | +192.4% | +100.2% | +9.5% | -21.4% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | – | – | – | +34.3% | +32.2% | +2.0% | -28.6% | +22.9% | +27.6% | |
| 營業外收入及支出合計 | – | – | +566.4% | -89.2% | – | -84.5% | +102.5% | -56.0% | -3.4% | +25.5% | |
| 稅前淨利（淨損） | – | +17.7% | +119.3% | -40.2% | +352.4% | -23.5% | +17.2% | -42.8% | -82.8% | -546.8% | |
| 所得稅費用（利益）合計 | – | -28.1% | -74.8% | +346.8% | +344.2% | -18.3% | +21.3% | -41.5% | -93.9% | -382.3% | |
| 繼續營業單位本期淨利（淨損） | – | +42.7% | +172.8% | -50.0% | +354.3% | -24.6% | +16.2% | -43.2% | -80.0% | -559.8% | |
| 本期淨利（淨損） | – | +42.7% | +172.8% | -50.0% | +354.3% | -24.6% | +16.2% | -43.2% | -80.0% | -559.8% | |
| 確定福利計畫之再衡量數 | – | – | -206.0% | – | -109.6% | – | +862.8% | -105.0% | – | -51.3% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目 | – | – | – | – | +69.0% | +703.1% | -174.0% | – | – | – | |
| 與不重分類之項目相關之所得稅 | – | – | -162.0% | – | -109.6% | – | +862.9% | -105.0% | – | -51.3% | |
| 不重分類至損益之項目： | – | – | – | – | +33.5% | +724.8% | -161.1% | – | – | -24.7% | |
| 國外營運機構財務報表換算之兌換差額 | – | – | – | -217.8% | – | – | – | -101.3% | – | -160.5% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | – | -184.2% | – | -489.0% | – | -94.3% | |
| 後續可能重分類至損益之項目： | – | – | – | – | – | – | – | -274.0% | – | -104.7% | |
| 其他綜合損益（淨額） | – | – | – | – | +87.0% | +714.5% | -159.6% | – | – | -52.2% | |
| 本期綜合損益總額 | – | +72.8% | +127.1% | -38.3% | +338.6% | -6.1% | -21.9% | -35.5% | -73.4% | -443.8% | |
| 母公司業主（淨利∕損） | – | +42.3% | +173.1% | -50.1% | +354.6% | -24.6% | +16.2% | -43.1% | -80.0% | -559.8% | |
| 母公司業主（綜合損益） | – | +72.3% | +127.3% | -38.4% | +338.8% | -6.1% | -22.0% | -35.4% | -73.4% | -443.8% | |
| 基本每股盈餘 | – | +42.3% | +172.1% | -50.0% | +354.3% | -24.6% | +16.2% | -43.1% | -72.2% | -562.1% | |
| 繼續營業單位淨利（淨損） | – | +42.9% | +171.8% | -49.8% | +352.7% | -24.6% | +15.8% | -42.8% | -72.3% | -567.0% | |
| 稀釋每股盈餘 | – | +42.9% | +171.8% | -49.8% | +352.7% | -24.6% | +15.8% | -42.8% | -72.3% | -567.0% | |
| 預期信用減損損失（利益） | – | – | – | – | – | – | -200.0% | – | – | – | |
| 非控制權益（淨利∕損） | – | – | -70.4% | +227.0% | +57.0% | +43.2% | +1.1% | -100.0% | – | – | |
| 非控制權益（綜合損益） | – | – | -62.6% | +202.7% | +50.9% | +55.0% | +5.0% | -100.0% | – | – | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | – | – | – | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | – | – | -100.0% | – | – | – | – | – | – | – | |
| 採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。